High Estrogen Work-Up in Males

Initial Diagnostic Evaluation

The American College of Endocrinology recommends measuring serum luteinizing hormone (LH) to establish the etiology of the hormonal abnormality, followed by serum prolactin to screen for hyperprolactinemia, with a strength of evidence level of high 1

Measuring serum LH levels helps differentiate between primary and secondary causes of elevated estrogen, with a high level of evidence supporting its use 1
Checking serum prolactin, especially when LH is abnormal, can help identify hyperprolactinemia as a cause of elevated estrogen, based on strong evidence 1
Obtaining specific estradiol measurement is recommended in patients presenting with breast symptoms or gynecomastia, with a moderate level of evidence supporting its use 1

Assessing for underlying malignancy, particularly estrogen receptor-positive breast cancer, requires specific management, with a high level of evidence supporting its importance 2, 3

For men with hormone-sensitive malignancies, the American Society of Clinical Oncology recommends using aromatase inhibitors (anastrozole or letrozole) combined with GnRH analogs, with a high level of evidence supporting its effectiveness 3
Aromatase inhibitors are only effective with complete ovarian/testicular suppression or ablation, with a moderate level of evidence supporting this statement 1

The American College of Clinical Endocrinologists recommends never using testosterone/androgen supplementation in men with breast cancer or elevated estrogen from hormone-sensitive malignancies, with a high level of evidence supporting this contraindication 3, 4
Testosterone aromatizes to estradiol, potentially stimulating estrogen receptor-positive cancer cells and causing recurrence or progression, with a high level of evidence supporting this mechanism 4

Regular monitoring of estradiol levels is necessary to assess treatment efficacy and adjust therapy accordingly, with a moderate level of evidence supporting its importance 1

For patients with antiphospholipid antibodies and elevated estrogen, prophylactic anticoagulation with heparin or low molecular weight heparin is recommended due to increased thrombosis risk, with a moderate level of evidence supporting this recommendation 1
Avoiding estrogen-containing medications in patients with hereditary angioedema is recommended, as elevated estradiol increases attack frequency and severity, with a moderate level of evidence supporting this recommendation 1
Monitoring cardiovascular risk factors in patients with chronic kidney disease is necessary, as the relationship between estradiol and cardiovascular protection may be altered, with a low level of evidence supporting this statement 1